Upload
Featured Recent Articles Topics Login Upload

Search Results for '3tc dtg'

3tc dtg published presentations and documents on DocSlides.

DTG + 3TC versus DTG + TDF-FTC as Initial ART
DTG + 3TC versus DTG + TDF-FTC as Initial ART
by della
GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
by jacey
1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...
DTG/3TC 1st line (GEMINI)
DTG/3TC 1st line (GEMINI)
by oryan
ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT
by jasmine
–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...
Switch to DTG/3TC TANGO Design
Switch to DTG/3TC TANGO Design
by lam
Endpoints. Primary: proportion of patients with HI...
Switch to DTG/ABC/3TC
Switch to DTG/ABC/3TC
by karlyn-bohler
STRIIVING . Study. Design. Endpoints. Primary: pr...
Meg Doherty MD MPH PhD 23 July 2018
Meg Doherty MD MPH PhD 23 July 2018
by jordyn
WHO HQ. The role of DTG based regimens in first- a...
Comparison of INSTI vs PI
Comparison of INSTI vs PI
by conchita-marotz
FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...
1 Fundación Huésped, Buenos Aires, Argentina;
1 Fundación Huésped, Buenos Aires, Argentina;
by aaron
2. Instituto Nacional de Ciencias Médicas y Nutr...
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on
by myesha-ticknor
Martina Penazzato MD, PhD. Paediatric lead, HIV D...
Comparison of INSTI vs EFV
Comparison of INSTI vs EFV
by mediumgeneral
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
WHO ARV Forecasting Meeting
WHO ARV Forecasting Meeting
by sistertive
Geneva, March 19 - 20 , 2015 1 | Treatment and C...
What’s new in the 2019 WHO Guidelines:
What’s new in the 2019 WHO Guidelines:
by elina
Dolutegravir based regimens in first- ad second-li...
Dolutegravir-Lamivudine (
Dolutegravir-Lamivudine (
by audrey
Dovato. ). Last Updated: November 28, 2022. Prepar...
DTG vs LPV/r (DAWNING): Efficacy
DTG vs LPV/r (DAWNING): Efficacy
by winnie
by Baseline NRTI Resistance . and Second-Line NRTI...
Interactive ART Cases From the Clinic: Is There One Right Answer?
Interactive ART Cases From the Clinic: Is There One Right Answer?
by megan
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
Treatment Approaches to Achieve the 2
Treatment Approaches to Achieve the 2
by gabriella
nd. 90: Child Friendly Formulations . Victor Mu...
Cases from the Clinic(ians): Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
HIV 2020: Time for change
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
Projecting the Impact of
Projecting the Impact of
by marina-yarberry
Generic. HIV . Drugs. on 90-90-90. Esteban Burr...
Updated WHO Treatment Guidelines &
Updated WHO Treatment Guidelines &
by mitsue-stanley
Data . from other . cohorts and . regions to guid...
Dolutegravir monotherapy
Dolutegravir monotherapy
by alexa-scheidler
Dolutegravir monotherapy vs. dolutegravir/ abac...
1 Queen Mary University, London, United Kingdom;
1 Queen Mary University, London, United Kingdom;
by trish-goza
1 Queen Mary University, London, United Kingdom; ...
HIV History successes and lessons learned
HIV History successes and lessons learned
by linda
PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
Thinking of Now and Tomorrow: Emerging Treatment Paradigms
by deena
Pedro Cahn. Disclosures. Advisory. . boards. : Me...
Optimization of Antiretroviral Therapy
Optimization of Antiretroviral Therapy
by belinda
With Emergence of Comorbidities. Roger J. . Bedimo...
Updates on Individual and Universal HIV Treatment Strategies
Updates on Individual and Universal HIV Treatment Strategies
by norah
EECA INTERACT, November 19, 2019. Stefan Baral, MD...
Introduction Characteristics, Treatment Patterns,
Introduction Characteristics, Treatment Patterns,
by cappi
and . Virologic. Outcomes . for Treatment-experie...
IAS – USA Fall New York Course: Case Discussion
IAS – USA Fall New York Course: Case Discussion
by jalin
Luke . Jerram. Disclosures: Educational grant supp...
Cases From the Clinic( ians
Cases From the Clinic( ians
by ImNotABaby
):. Antiretroviral Therapy Cases . and . Panel Dis...
Michael S. Saag , MD Professor of Medicine
Michael S. Saag , MD Professor of Medicine
by roxanne
Associate Dean for Global Health. University of Al...
Joel E. Gallant, MD, MPH
Joel E. Gallant, MD, MPH
by mastervisa
Medical Director, Specialty . Services. Southwest ...
Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)
Treating and Preventing HIV in 2019: Interactive Cases From the Clinic(ians)
by alida-meadow
Treating and Preventing HIV in 2019: Interactive ...
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
Rajesh T. Gandhi, MD Director, HIV Clinical Services and Education
by calandra-battersby
Massachusetts General Hospital. Boston, Massachus...
Highlights for clinical
Highlights for clinical
by pasty-toler
. practice. HIV. International Congress of Drug ...
Dual Antiretroviral Therapy
Dual Antiretroviral Therapy
by debby-jeon
This program will include a discussion of off-lab...